Therapeutic effects of hepatocyte growth factor‐overexpressing human umbilical cord blood‐derived mesenchymal stem cells on liver fibrosis in rats
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Fibrosis is a common end stage for a variety of liver diseases, including most chronic liver diseases, and results from an imbalance between collagen deposition and degradation. Mesenchymal stem cells (MSCs) have the ability to migrate into fibrotic livers and differentiate into hepatocytes. Hepatocyte growth factor (HGF) has potent anti‐apoptotic and mitogenic effects on hepatocytes during liver injury and plays an essential role in the development and regeneration of the liver. In this study, human HGF‐overexpressing human umbilical cord blood‐derived MSCs (hHGF‐HUCB‐MSCs) were prepared using the pMEX Expression System, and the upregulation of hHGF expression was confirmed by RT‐PCR and ELISA. HGF expressed by hHGF‐HUCB‐MSCs exerted a stimulatory effect on hepatocyte proliferation in vitro. hHGF‐HUCB‐MSCs were transplanted to investigate the therapeutic effects of these cells on carbon tetrachloride (CCL 4)‐induced liver fibrosis in a rat model. After 4 weeks of cell treatment once per week with 2 × 10 6 cells, biochemical analysis of the serum and histopathological analysis of the liver tissue were performed. The results of the biochemical analysis of the serum show that the hHGF‐HUCB‐MSC‐treated group had higher levels of alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase, indicating the improvement of liver function. Histopathology showed that the hHGF‐HUCB‐MSC‐treated group had reduction in the density of collagen fibres. Thus hHGF‐HUCB‐MSCs can enhance liver regeneration and could be useful for the treatment of patients with liver fibrosis or cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 2×
“…regeneration of endogenous parenchymal cells, suggesting that MSCs may be ideally suited for the treatment of liver diseases involving fibrosis (Haynesworth et al., 1996; Fang et al., 2004; Zhao et al., 2004; Zhao et al., 2005; Caplan and Dennis, 2006; Parekkadan et al., 2007; Kuo et al., 2008).”
BackgroundIsolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
In vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
Lee, K., Kuo, T. K., Whang–Peng, J., Chung, Y., Lin, C., Chou, S., Chen, J., Chen, Y., & Lee, O. K. (2004) · Hepatology · doi:10.1002/hep.20469 · Cited by 865 · cited 1×
“Regarding liver regeneration, HUCB-MSCs can differentiate into hepatocytes in vitro (Kang et al., 2005; Lee et al., 2004a, b) and in vivo (Newsome et al., 2003); and transplantation of HUCB-MSCs can also suppress fibrotic 112 Cell Biol Int 38 (2014) 106–116 2013 International Federation for Cell…”
BackgroundSato, Y., Araki, H., Kato, J., Nakamura, K., Kawano, Y., Kobune, M., Sato, T., Miyanishi, K., Takayama, T., Takahashi, M., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0572 · Cited by 610
Kuo, T. K., Hung, S., Chuang, C., Chen, C., Shih, Y. V., Fang, S. Y., Yang, V. W., & Lee, O. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.015 · Cited by 466 · cited 2×
“…regeneration of endogenous parenchymal cells, suggesting that MSCs may be ideally suited for the treatment of liver diseases involving fibrosis (Haynesworth et al., 1996; Fang et al., 2004; Zhao et al., 2004; Zhao et al., 2005; Caplan and Dennis, 2006; Parekkadan et al., 2007; Kuo et al., 2008).”
BackgroundZhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07024.x · Cited by 372 · cited 2×
“The therapeutic potential of HUCB-MSCs for treating liver cirrhosis has also been noted (Alvarez-Mercado et al., 2009; Jung et al., 2009; Bassiouny et al., 2011; Kim et al., 2011; Zhang et al., 2012).”
BackgroundHong, S. H., Gang, E. J., Jeong, J. A., Ahn, C., Hwang, S. H., Yang, I. H., Park, H. K., Han, H., & Kim, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.086 · Cited by 248 · cited 3×
“HUCB-MSCs have many advantages over BM in the procurement and transplantation of cells, such as high abundance, lack of donor attrition, low risk of viral transmission and a less pronounced immune response (Hong et al., 2005), which can lead to better engraftment in non-immunodeficient recipients (Surbek et al.”
BackgroundInsertional Mutagenesis of AAV2 Capsid and the Production of Recombinant Virus
Rabinowitz, J. E., Xiao, W., & Samulski, R. J. (1999) · Virology · doi:10.1006/viro.1999.0045 · Cited by 136 · cited 2×
“…can induce efficient gene expression in hepatocytes in vivo; however, these vectors can lead to transient gene expression and give some side effects, for example cytotoxicity and immune responses (Li et al., 1993; Yang et al., 1994; Marshall, 1999; Powell et al., 1999; Rabinowitz et al., 1999).”
Background
Cited by
Pathogenesis of liver cirrhosis
Zhou, W.-C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7312 · Cited by 627
Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
Yang, X., Li, Q., Liu, W., Zong, C., Wei, L., Shi, Y., & Han, Z. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00983-5 · Cited by 120
Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine
Nowakowski, A., Walczak, P., Janowski, M., & Lukomska, B. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0062 · Cited by 38
Bolinas, D. K. M., Barcena, A. J. R., Mishra, A., Bernardino, M. R., Lin, V., Heralde, F. M., Chintalapani, G., Fowlkes, N. W., Huang, S. Y., & Melancon, M. P. (2025) · Gels · doi:10.3390/gels11040250 · Cited by 20
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
Kholodenko, I. V., Kholodenko, R. V., & Yarygin, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015212 · Cited by 16
Metadata
- Authors
- Seo, K., Sohn, S., Bhang, D., Nam, M., Lee, H., & Youn, H.
- Venue
- Cell Biology International
- Publisher
- Wiley
- Published
- 2013-10-17
- Volume
- 38
- Issue
- 1
- Pages
- 106-116
- ISSN
- 1065-6995 (ISSN-L)
- 1095-8355
- OpenAlex
- W2152611577
- Cited by
- 50
- References
- 8
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.